Back to LYEL

CHARLES SCHWAB INVESTMENT MANAGEMENT INC → LYEL

CHARLES SCHWAB INVESTMENT MANAGEMENT INC LYEL Position History

Lyell Immunopharma, Inc. • Healthcare

Quarters held
4
Latest value
$912K
Q3 2026
Peak value
$2.6M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$2.6M
Q1 2026$1.7M
Q2 2026$1.5M
Q3 2026$912K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$912K93.1K——
Q2 2026$1.5M107.6K——
Q1 2026$1.7M86.0K——
Q4 2025$2.6M85.4K——

Other funds holding LYEL

Other CHARLES SCHWAB INVESTMENT MANAGEMENT INC positions

NVDA

NVIDIA CORPORATION

$38.2B
AAPL

APPLE INC

$34.9B
NVDA

NVIDIA CORPORATION

$32.1B
AAPL

APPLE INC

$29.3B
NVDA

NVIDIA CORPORATION

$29.1B
NVDA

NVIDIA CORPORATION

$28B
MSFT

MICROSOFT CORP

$28B
AAPL

APPLE INC

$27.1B